GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Digicann Ventures Inc (XCNQ:DCNN) » Definitions » Research & Development

Digicann Ventures (XCNQ:DCNN) Research & Development : C$0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Digicann Ventures Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Digicann Ventures's Research & Development for the three months ended in Mar. 2024 was C$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was C$0.00 Mil.

Digicann Ventures Research & Development Historical Data

The historical data trend for Digicann Ventures's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Digicann Ventures Research & Development Chart

Digicann Ventures Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.40 0.40 - - -

Digicann Ventures Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Digicann Ventures Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Digicann Ventures  (XCNQ:DCNN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Digicann Ventures Research & Development Related Terms

Thank you for viewing the detailed overview of Digicann Ventures's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Digicann Ventures (XCNQ:DCNN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Digicann Ventures Inc (XCNQ:DCNN) » Definitions » Research & Development
Comparable Companies
XCNQ:MJRX XCNQ:CHM XCNQ:ASIA XCNQ:SE XCNQ:JOLT TSXV:VIV XCNQ:PLNT.X TSXV:HMPG XCNQ:XCX XCNQ:OMND ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 XSWX:SDZ VTRS NBIX
Traded in Other Exchanges
AGFAF:USA
Address
789 West Pender Street, Suite 810, Vancouver, BC, CAN, V6C1H2
Website
https://www.agraventures.com
Digicann Ventures Inc Formerly Agra Ventures Ltd is a pharmaceutical company engaged in the sale of cannabis-related products. The company's geographic segment includes Germany and Canada, with the majority of sales coming from Germany.
Executives
Nicholas Jonathan Kuzyk Director, Senior Officer

Digicann Ventures (XCNQ:DCNN) Headlines

No Headlines